HIMS Insider Trading

Insider Ownership Percentage: 17.71%
Insider Buying (Last 12 Months): $2,084,023.00
Insider Selling (Last 12 Months): $96,281,855.25

Hims & Hers Health Insider Trading History Chart

This chart shows the insider buying and selling history at Hims & Hers Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$3.70MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M$0$20MTotal Insider BuyingTotal Insider Selling

Hims & Hers Health Share Price & Price History

Current Price: $35.08
Price Change: Price Increase of +6.6 (23.17%)
As of 04/29/2025 04:59 PM ET

This chart shows the closing price history over time for HIMS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$28.51Closing price on 04/28/25:

SEC Filings (Institutional Ownership Changes) for Hims & Hers Health (NYSE:HIMS)

63.52% of Hims & Hers Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HIMS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$64Mbought$31MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1B$0$1BTotal InflowsTotal Outflows
Hims & Hers Health logo
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Read More on Hims & Hers Health

Today's Range

Now: $35.08
Low: $32.95
High: $37.94

50 Day Range

MA: $33.44
Low: $25.41
High: $66.28

52 Week Range

Now: $35.08
Low: $11.20
High: $72.98

Volume

151,962,981 shs

Average Volume

16,261,208 shs

Market Capitalization

$7.79 billion

P/E Ratio

79.73

Dividend Yield

N/A

Beta

1.65

Who are the company insiders with the largest holdings of Hims & Hers Health?

Hims & Hers Health's top insider investors include:
  1. Melissa Baird (COO)
  2. Andrew Dudum (CEO)
  3. Oluyemi Okupe (CFO)
  4. Patrick Harrison Carroll (Insider)
  5. Michael Chi (Insider)
  6. Soleil Boughton (Insider)
  7. Christopher D Payne (Director)
  8. Christiane Pendarvis (Director)
  9. Irene Becklund (Insider)
  10. Anja Manuel (Director)
  11. Lynne Chou O'keefe (Director)
Learn More about top insider investors at Hims & Hers Health.

Who are the major institutional investors of Hims & Hers Health?

Hims & Hers Health's top institutional shareholders include:
  1. IMC Chicago LLC — 0.00%
  2. Principal Financial Group Inc. — 0.36%
  3. Rhumbline Advisers — 0.27%
  4. Salem Investment Counselors Inc. — 0.12%
  5. Retirement Systems of Alabama — 0.10%
  6. New York State Teachers Retirement System — 0.09%
Learn More about top institutional investors of Hims & Hers Health stock.

Which institutional investors are selling Hims & Hers Health stock?

In the previous quarter, HIMS stock was sold by these institutional investors:
  1. Principal Financial Group Inc.
  2. SG Americas Securities LLC
  3. State of Alaska Department of Revenue
  4. Teacher Retirement System of Texas
  5. Means Investment CO. Inc.
  6. Robeco Institutional Asset Management B.V.
  7. Cullinan Associates Inc.
  8. Oregon Public Employees Retirement Fund
In the last year, company insiders that have sold Hims & Hers Health company stock include:
  1. Melissa Baird (COO)
  2. Andrew Dudum (CEO)
  3. Oluyemi Okupe (CFO)
  4. Patrick Harrison Carroll (Insider)
  5. Michael Chi (Insider)
  6. Soleil Boughton (Insider)
  7. Christopher D Payne (Director)
  8. Christiane Pendarvis (Director)
Learn More investors selling Hims & Hers Health stock.

Which institutional investors are buying Hims & Hers Health stock?

In the previous quarter, HIMS stock was purchased by institutional investors including:
  1. Salem Investment Counselors Inc.
  2. Retirement Systems of Alabama
  3. GAMMA Investing LLC
  4. Kessler Investment Group LLC
  5. New York State Teachers Retirement System
  6. Abacus FCF Advisors LLC
  7. Rhumbline Advisers
  8. Global Assets Advisory LLC
In the previous year, these company insiders have bought Hims & Hers Health stock:
  1. Melissa Baird (COO)
  2. Andrew Dudum (CEO)
Learn More investors buying Hims & Hers Health stock.